# Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

> **NCT06892249** · NA · COMPLETED · sponsor: **Fresenius Kabi Taiwan Ltd.** · enrollment: 74 (actual)

## Conditions studied

- CKD
- Low Protein Dietary Intake
- Malnutrition (Calorie)

## Interventions

- **DIETARY_SUPPLEMENT:** Renalive® LP, flavour Vanilla
- **DIETARY_SUPPLEMENT:** Renalive® LP, flavour Cappuccino

## Key facts

- **NCT ID:** NCT06892249
- **Lead sponsor:** Fresenius Kabi Taiwan Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-04
- **Primary completion:** 2026-04-21
- **Final completion:** 2026-04-21
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06892249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06892249, "Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06892249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*